Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial

被引：0

作者：

Saliba, Faouzi ^{[1
]}

De Simone, Paolo ^{[2
]}

Nevens, Frederik ^{[3
]}

De Carlis, Luciano ^{[4
]}

Metselaar, Herold ^{[5
]}

Beckebaum, Susanne ^{[6
]}

Jonas, Sven ^{[7
]}

Sudan, Debra ^{[8
]}

Fischer, Lutz ^{[9
]}

Fung, John J. ^{[10
]}

Dong, Gaohong ^{[11
]}

Lopez, Patricia M. ^{[12
]}

Junge, Guido ^{[12
]}

机构：

[1] Hop Paul Brousse, Villejuif, France

[2] Azienda Osped Univ Pisana, Pisa, Italy

[3] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium

[4] Osped Niguarda Ca Granda, Milan, Italy

[5] Univ Rotterdam Hosp, Erasmus MC, Rotterdam, Netherlands

[6] Univ Hosp Essen, Essen, Germany

[7] Univ Med Ctr Leipzig, Leipzig, Germany

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[11] Novartis Pharmaceut, E Hanover, NJ USA

[12] Novartis Pharma AG, Basel, Switzerland

来源：

HEPATOLOGY | 2012年 / 56卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB5

引用

页码：1519 / 1519

页数：1

共 50 条

[31] Efficacy and Safety of Everolimus with Early Reduction or Elimination of Tacrolimus in 719 de Novo Liver Transplant Recipients - Results at 12 Months [J].

De Simone, P. ;

Nevens, F. ;

Duvoux, C. ;

Koneru, B. ;

McCormack, L. ;

McCaughan, G. ;

Navasa, M. ;

Dong, G. ;

Hexham, J. M. ;

Junge, G. ;

Fung, J. .

TRANSPLANTATION, 2012, 94 (10) :750-750

[32] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 12 MONTHS [J].

Saliba, Faouzi ;

Duvoux, Christophe ;

Durand, Francois ;

Neau-Cransac, Martine ;

Hardwigsen, Jean ;

Pageaux, Georges ;

Boleslawski, Emmanuel .

TRANSPLANT INTERNATIONAL, 2012, 25 :39-39

[33] Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data [J].

Qazi, Y. ;

Shaffer, D. ;

Kaplan, B. ;

Kim, D. Y. ;

Luan, F. L. ;

Peddi, V. R. ;

Shihab, F. ;

Tomlanovich, S. ;

Yilmaz, S. ;

McCague, K. ;

Patel, D. ;

Mulgaonkar, S. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (05) :1358-1369

[34] Improvement of renal function with everolimus plus reduced tacrolimus in de novo liver transplant recipients - HEPHAISTOS study 12 month data. [J].

Schlitt, H. J. ;

Nashan, B. ;

Braun, F. ;

Pascher, A. ;

Klein, C. -G ;

Neumann, U. ;

Kroeger, I ;

Wimmer, P. ;

Schemmer, P. .

TRANSPLANTATION, 2019, 103 (08) :46-46

[35] EARLY TACROLIMUS WITHDRAWAL AFTER LIVER TRANSPLANTATION PROVIDES IMPROVEMENT OF RENAL FUNCTION VS. EVEROLIMUS-FACILITATED REDUCED-EXPOSURE TACROLIMUS: RESULTS OF A NATIONAL PILOT STUDY [J].

De Simone, Paolo ;

Tisone, Giuseppe ;

Di Benedetto, Fabrizio ;

Pinna, Antonio Daniele ;

Tedeschi, Umberto ;

Baccarani, Umberto ;

Lupo, Luigi Giovanni ;

Fagiuoli, Stefano ;

Cillo, Umberto .

TRANSPLANT INTERNATIONAL, 2017, 30 :66-66

[36] The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months. [J].

De Simone, P. ;

Kaiser, G. M. ;

De Carlis, L. ;

Metselaar, H. J. ;

Duvoux, C. ;

Nevens, F. ;

Fischer, L. ;

Fung, J. ;

Dong, G. ;

Rauer, B. ;

Junge, G. ;

Saliba, F. .

LIVER TRANSPLANTATION, 2014, 20 :S106-S106

[37] Efficacy and safety of everolimus in combination with reduced tacrolimus in de novo liver transplant recipients: 36-month results from the randomized H2304 study [J].

Saliba, Faouzi ;

Kaiser, Gernot M. ;

De Carlis, Luciano ;

Metselaar, Herold J. ;

De Simone, Paolo ;

Duvoux, Christophe ;

Nevens, Frederik ;

Fischer, Lutz ;

Fung, John J. ;

Dong, Gaohong ;

Rauer, Barbara ;

Junge, Guido .

HEPATOLOGY, 2013, 58 (06) :1383A-1383A

[38] EFFECT OF TACROLIMUS EXPOSURE ON EVEROLIMUS-BASED IMMUNOSUPPRESSION IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: A 24-MONTH ANALYSIS FROM TRANSFORM STUDY [J].

Citterio, Franco ;

Peddi, V. Ram ;

Qazi, Yasir ;

Kim, Dean ;

Vincenti, Flavio ;

Berger, Stefan ;

Sommerer, Claudia ;

Gawai, Apurva ;

Hernandez-Gutierrez, Maria-Pilar ;

Bernhardt, Peter ;

Oberbauer, Rainer .

TRANSPLANT INTERNATIONAL, 2021, 34 :254-255

[39] EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY [J].

Saliba, F. ;

Duvoux, C. ;

Durand, F. ;

Neau-Cransac, M. ;

Hardwigsen, J. ;

Pageaux, G. ;

Di Giambattista, F. .

TRANSPLANT INTERNATIONAL, 2015, 28 :18-18

[40] An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients [J].

Sommerer, Claudia ;

Suwelack, Barbara ;

Dragun, Duska ;

Schenker, Peter ;

Hauser, Ingeborg A. ;

Witzke, Oliver ;

Hugo, Christian ;

Kamar, Nassim ;

Merville, Pierre ;

Junge, Martina ;

Thaiss, Friedrich ;

Nashan, Bjoern ;

Almartine, Eric ;

Dantal, Jacques ;

Dragun, Duska ;

Feldkamp, Thorsten ;

Hauser, Ingeborg A. ;

Hazzan, Marc ;

Heyne, Nils ;

Hugo, Christian ;

Kamar, Nassim ;

Lang, Philippe ;

Lehner, Frank ;

Le Meur, Yannick ;

Lutz, Jens ;

Merville, Pierre ;

Morelon, Emmanuel ;

Moulin, Bruno ;

Mousson, Christiane ;

Muehlfeld, Anja ;

Nashan, Bjorn ;

Pisarski, Przemyslaw ;

Rondeau, Eric ;

Schenker, Peter ;

Sommerer, Claudia ;

Suwelack, Barbara ;

Thaiss, Friedrich ;

Thierry, Antoine ;

Wiesener, Michael ;

Witzke, Oliver .

KIDNEY INTERNATIONAL, 2019, 96 (01) :231-244

← 1 2 3 4 5 →